Sign In
Last checked at 
23 Feb 2022 09:00
SMITH & NEPHEW PLC
Ā
23 February 2022
Ā
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM.
Ā
Smith & Nephew plc (the "Company") announces that it has been informed of changes to the share interests of PDMRs in the Company, detailed below, following completion of the related performance periods.
Ā
Smith & Nephew Global Share Plan 2010 (Performance Share Awards):
Ā
The following relates to individuals included in the below notification:
Ā
Reason for the notification | |
Initial notification /Amendment | Initial notification |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
Name | Smith & Nephew plc |
LEI | 213800ZTMDN8S67S1H61 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
Description of the financial instrument, type of instrument Ā | Smith & Nephew plc ordinary shares of USD 0.20 each Ā |
Identification code | ISIN: GB0009223206 |
Nature of the transaction | Lapse of a Performance Share Award granted on 7 March 2019 under the Smith & Nephew Global Share Plan 2010 |
Date of Transaction | 2022 - 02 - 22 |
Place of Transaction | Lapse took place outside a trading venue |
Ā
Name of PDMR (Position) | Number of ordinary shares under award granted on 07/03/2019 (shown at maximum) | Number of ordinary shares lapsed under award (shown at maximum) | Number of ordinary shares outstanding under award (shown at maximum) |
Helen Barraclough (Group General Counsel) | 12,054 | 12,054 | 0 |
Bradley Cannon (President, Orthopaedics, Sports Medicine & ENT and Americas) | 30,784 | 30,784 | 0 |
Phil Cowdy (Chief Business Development & Corporate Affairs Officer) | 22,564 | 22,564 | 0 |
Simon Fraser (President, Advanced Wound Management & Global Commercial Operations) | 27,166 | 27,166 | 0 |
Elga Lohler (Chief HR Officer) | 26,722 | 26,722 | 0 |
Vasant Padmanabhan (President, Research & Development) | 26,382 | 26,382 | 0 |
Susan Swabey (Company Secretary) | 9,784 | 9,784 | 0 |
Ā
Notes:
Ā
(i) Following completion of the performance measurement period, these awards lapsed in full on 22 February 2022.
Ā
(ii) Details regarding the performance against targets as set at the grant date will be disclosed within the Annual Report which is to be published on 7 March 2022.
Ā
This announcement is made in accordance with the requirements of Article 19 (3) of the Market Abuse Regulation.
Ā
Sarah Carne
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0) 1923 477100
Follow the stocks
